 | • レポートコード：MRC2111A044 • 出版社/出版日：Transparency Market Research / 2021年7月30日 • レポート形態：英文、PDF、225ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、植物由来ワクチンの世界市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（細菌ワクチン、ウイルスワクチン、その他）分析、植物原料別分析、用途別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・植物由来ワクチンの世界市場規模：種類別（細菌ワクチン、ウイルスワクチン、その他） ・植物由来ワクチンの世界市場規模：植物原料別 ・植物由来ワクチンの世界市場規模：用途別 ・植物由来ワクチンの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Plant-based Vaccines Market – Scope of Report
TMR’s report on the global plant-based vaccines market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global plant-based vaccines market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global plant-based vaccines market during the forecast period.
The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ annual reports, press releases, and relevant documents to understand the global plant-based vaccines market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global plant-based vaccines market.
The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global plant-based vaccines market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global plant-based vaccines market.
The report delves into the competitive landscape of the global plant-based vaccines market. Key players operating in the global plant-based vaccines market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global plant-based vaccines market that have been profiled in this report.
Key Questions Answered in Plant-based Vaccines Market Report
What is the scope of growth of plant-based vaccines and providers in the global plant-based vaccines market and its segments?
What will be the Y-o-Y growth of the global plant-based vaccines market between 2020 and 2030?
What is the influence of changing trends in technologies on the global plant-based vaccines market?
Will North America continue to be the most profitable market for plant-based vaccines providers?
Which factors will hamper the global plant-based vaccines market during the forecast period?
Which are the leading companies in the global plant-based vaccines market?
Research Methodology
TMR has utilized a unique research methodology to conduct a comprehensive research on the growth of the global plant-based vaccines market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the global plant-based vaccines market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, device portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to TMR’s study on the global plant-based vaccines market’s primary sources.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from plant-based vaccines market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global plant-based vaccines market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global plant-based vaccines market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Plant-based Vaccines Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Plant-based Vaccines Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.3. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
5.4. Overview of Plant-based Vaccines
6. Global Plant-based Vaccines Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
6.3.1. Bacterial Vaccine
6.3.2. Viral Vaccine
6.3.3. Others
6.4. Global Plant-based Vaccines Market Attractiveness, by Type
7. Global Plant-based Vaccines Market Analysis and Forecast, by Plant source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
7.3.1. Tobacco
7.3.2. Potato
7.3.3. Others
7.4. Global Plant-based Vaccines Market Attractiveness, by Plant source
8. Global Plant-based Vaccines Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
8.3.1. Against Infectious Agents
8.3.2. Anti-Cancer
8.3.3. Against Autoimmune Disorders
8.4. Global Plant-based Vaccines Market Attractiveness, by Application
9. Global Plant-based Vaccines Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Plant-based Vaccines Market Attractiveness, by Country/Region
10. North America Plant-based Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
10.2.1. Bacterial Vaccine
10.2.2. Viral Vaccine
10.2.3. Others
10.3. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
10.3.1. Tobacco
10.3.2. Potato
10.3.3. Others
10.4. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
10.4.1. Against Infectious Agents
10.4.2. Anti-Cancer
10.4.3. Against Autoimmune Disorders
10.5. North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Plant-based Vaccines Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Plant source
10.6.3. By Application
10.6.4. By Country
11. Europe Plant-based Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Plant-based Vaccines Market Value (US$ Mn) Market Value Forecast, by Type, 2017–2031
11.2.1. Bacterial Vaccine
11.2.2. Viral Vaccine
11.2.3. Others
11.3. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
11.3.1. Tobacco
11.3.2. Potato
11.3.3. Others
11.4. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
11.4.1. Against Infectious Agents
11.4.2. Anti-Cancer
11.4.3. Against Autoimmune Disorders
11.5. Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Plant-based Vaccines Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Plant source
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Plant-based Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
12.2.1. Bacterial Vaccine
12.2.2. Viral Vaccine
12.2.3. Others
12.3. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
12.3.1. Tobacco
12.3.2. Potato
12.3.3. Others
12.4. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
12.4.1. Against Infectious Agents
12.4.2. Anti-Cancer
12.4.3. Against Autoimmune Disorders
12.5. Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Plant-based Vaccines Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Plant source
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Plant-based Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
13.2.1. Bacterial Vaccine
13.2.2. Viral Vaccine
13.2.3. Others
13.3. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
13.3.1. Tobacco
13.3.2. Potato
13.3.3. Others
13.4. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
13.4.1. Against Infectious Agents
13.4.2. Anti-Cancer
13.4.3. Against Autoimmune Disorders
13.5. Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Plant-based Vaccines Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Plant source
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Plant-based Vaccines Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
14.2.1. Bacterial Vaccine
14.2.2. Viral Vaccine
14.2.3. Others
14.3. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant source, 2017–2031
14.3.1. Tobacco
14.3.2. Potato
14.3.3. Others
14.4. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
14.4.1. Against Infectious Agents
14.4.2. Anti-Cancer
14.4.3. Against Autoimmune Disorders
14.5. Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Plant-based Vaccines Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Plant source
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2020)
15.3. Company Profiles
15.3.1. Creative Biolabs
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Medicago Inc.
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. iBio
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Fraunhofer Center for Manufacturing Innovation
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. ICON
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. EEA Consulting Engineers
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Protalix
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Kentucky BioProcessing, Inc.
15.3.8.1. Company Overview
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Other Prominent Key Players
Table 01: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 03: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Plant-based Vaccines Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 08: North America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 09: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 12: Europe Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 16: Asia Pacific Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 17: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 20: Latin America Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 21: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Plant Source, 2017–2031
Table 24: Middle East & Africa Plant-based Vaccines Market Value (US$ Mn) Forecast, by Application, 2017–2031